相关实验视频

Updated: Sep 14, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

高LRIG1表达预测了患有子宫癌的患者的淋巴结转移

Pernilla Israelsson¹, Lisa Lif¹, Husam Oda²

¹Department of Diagnostics and Intervention, Oncology, Umeå University Hospital, Umeå, Sweden.

|July 24, 2025

概括

富含白的重复和免疫球蛋白类域蛋白1 (LRIG1) 可能预测早期宫癌的淋巴结转移. 高LRIG1表达表明风险更高,可能改善患者的分期和治疗决策.

科学领域:

在瘤学瘤学.
生物标志物发现发现
妇科病理学妇科病理学

背景情况:

淋巴结转移 (LNM) 影响早期宫癌 (IA2-IB1) 的治疗和预后.
目前对LNM的诊断方法有局限性,需要新的生物标志物来准确分期.
富含白的重复和免疫球蛋白类域蛋白1 (LRIG1) 涉及到生长因子信号和癌症预后.

研究的目的:

研究LRIG1表达的潜力,作为在子宫癌中淋巴结转移的预测生物标志物.
为了将LRIG1表达水平与淋巴结状况和其他临床病理因素相关联.

主要方法:

从67名宫癌患者 (31名LNM阴性,36名LNM阳性) 的瘤组织中LRIG1表达的免疫组织化学分析.
LRIG1免疫活性与淋巴结状况,人类乳头瘤病毒状况和吸烟状况的相关性.
统计分析,包括为相关共变量调整的赔率比率计算.

主要成果:

高LRIG1表达 (>>25%的阳性细胞) 与淋巴结转移的风险增加显著相关 (几率比为9.49,P = 0.008).
LRIG1表达显示出作为预测生物标志物的潜力,独立于年龄,吸烟状况和BMI.
这些发现表明LRIG1与宫癌转移潜力之间存在联系.

结论:

LRIG1表达可以作为一个有价值的生物标志物,用于预测早期宫癌的淋巴结转移.
需要在更大的多中心研究中进一步验证,以确认LRIG1的临床效用.
识别患有LNM高风险的患者可以完善治疗策略,并可能减少与治疗相关的副作用.

关键词:

这是一个HPVHPVHPV.一个LRIG1的LRIG1.淋巴结转移是淋巴结的转移.p16 p16 在这个问题上.子宫癌子宫癌子宫癌

更多相关视频

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...